Gen-Probe Announces Webcast of First Quarter 2004 Earnings Conference Call
SAN DIEGO--(BUSINESS WIRE)--April 19, 2004--Gen-Probe Incorporated (Nasdaq:GPRO) today announced that it will release its first quarter 2004 financial results on Monday, May 3, 2004 at approximately 4:00 p.m. Eastern Daylight Time (EDT). The announcement will be followed by a conference call at 4:30 p.m. hosted by Henry L. Nordhoff, chairman, president and CEO and Herm Rosenman, vice president, finance and CFO.
The conference call will be webcast live and may be accessed on the investor relations section of the Company's web site at www.gen-probe.com. Following the conference call, an archived version of the webcast will be available on the same web site for approximately 90 days. A replay will also be available through May 5, 2004. To access the replay, please call 1-800-934-9838 (U.S.) or 402-220-4875 (international).
About Gen-Probe Incorporated
Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid testing products used for the clinical diagnosis of human diseases and for screening donated human blood. Using its patented NAT technology, Gen-Probe has received FDA approvals or clearances for a broad portfolio of products that detect a variety of infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections. Additionally, the Company developed and manufactures the only FDA-approved blood screening assay for the simultaneous detection of HIV-1 and HCV, which is marketed by Chiron Corporation. Gen-Probe has 20 years of nucleic acid detection research and product development experience, and its products are used daily in clinical laboratories and blood collection centers throughout the world. Gen-Probe is headquartered in San Diego, California and has more than 700 employees. Additional information about the Company can be found at www.gen-probe.com.
Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance, are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as "believe," "will," "expect," "anticipate," "estimate," "intend," "plan," and "would." For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry ranking, plans and objectives of management, markets for our common stock and future management and organizational structure are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including our Report on Form 10-K for the year ended December 31, 2003 and all our periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.